Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Brainstorm Cell Therapeutics Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +3 vs. Q3 2022
- Shares held
- 3.70M
- −90.4K (−2.4%) vs. Q3 2022
- Total value
- $6.16M
- −$10.6M (−63.3%) vs. Q3 2022
- New holders
- 7
- 7 more added
- Sold out
- 4
- 11 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 5 | $1.73K |
| Q2 2025 | 34 | $264.0K |
| Q1 2025 | 32 | $1.09M |
| Q4 2024 | 34 | $560.3K |
| Q3 2024 | 38 | $2.52M |
| Q2 2024 | 48 | $4.09M |
| Q1 2024 | 47 | $2.19M |
| Q4 2023 | 46 | $1.04M |
| Q3 2023 | 53 | $928.4K |
| Q2 2023 | 57 | $11.5M |
| Q1 2023 | 48 | $20.4M |
| Q4 2022 | 43 | $6.16M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 48 | $11.0M |
| Q1 2022 | 39 | $14.0M |
| Q4 2021 | 42 | $17.6M |
| Q3 2021 | 52 | $16.9M |
| Q2 2021 | 57 | $21.4M |
| Q1 2021 | 75 | $32.1M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Brainstorm Cell Therapeutics Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Westside Investment Management, Inc. | 200 | $0 | 0.00% | 00.0% | Unchanged |
| NewSquare Capital LLC | 70 | $115 | 0.00% | +70 | New |
| Mark Sheptoff Financial Planning, LLC | 100 | $164 | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 133 | $218 | 0.00% | +133 | New |
| BNP Paribas Arbitrage, SA | 364 | $597 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,056 | $2.00K | 0.00% | +1,056 | New |
| Harbour Investments, Inc. | 1,781 | $2.92K | 0.00% | −853−32.4% | Reduced |
| Royal Bank of Canada | 1,533 | $3.00K | 0.00% | 00.0% | Unchanged |
| Washington Trust Co | 2,500 | $4.10K | 0.00% | 00.0% | Unchanged |
| Institutional & Family Asset Management, LLC | 3,000 | $4.92K | 0.00% | 00.0% | Unchanged |
| Bangor Savings Bank | 4,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 5,831 | $9.56K | 0.00% | +427+7.9% | Added |
| UBS Group AG | 7,500 | $12.3K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 8,200 | $13.4K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 11,039 | $16.0K | 0.00% | +200+1.8% | Added |
| Simplex Trading, LLC | 11,048 | $18.0K | 0.00% | +10,848+5,424.0% | Added |
| Charles Schwab Investment Management Inc | 11,287 | $18.5K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 11,800 | $19.0K | 0.00% | −43,900−78.8% | Reduced |
| Bank of New York Mellon Corp | 11,994 | $19.7K | 0.00% | +466+4.0% | Added |
| S.C. Financial Services, Inc. | 12,686 | $20.8K | 0.03% | +12,686 | New |
| Jane Street Group, LLC | 14,054 | $23.0K | 0.00% | +14,054 | New |
| Citadel Advisors LLC | 16,464 | $27.0K | 0.00% | −14,543−46.9% | Reduced |
| Group One Trading, L.P. | 16,978 | $27.8K | 0.00% | +16,978 | New |
| Boothbay Fund Management, LLC | 19,098 | $31.3K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 19,871 | $32.6K | 0.00% | −512−2.5% | Reduced |
| Janney Montgomery Scott LLC | 20,000 | $33.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 24,096 | $39.5K | 0.00% | −12,421−34.0% | Reduced |
| Creative Planning | 25,681 | $42.1K | 0.00% | −5,000−16.3% | Reduced |
| Marshall Wace, LLP | 37,582 | $61.6K | 0.00% | +24,558+188.6% | Added |
| Jmac Enterprises LLC | 40,430 | $66.3K | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 41,618 | $68.0K | 0.00% | −101,741−71.0% | Reduced |
| Northern Trust Corp | 55,916 | $91.7K | 0.00% | 00.0% | Unchanged |
| Weaver Consulting Group | 65,947 | $108.2K | 0.06% | −28,025−29.8% | Reduced |
| IFP Advisors, Inc | 26,650 | $139.0K | 0.00% | −2,200−7.6% | Reduced |
| State Street Corp | 96,060 | $157.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 106,071 | $174.0K | 0.00% | +106,071 | New |
| Price T Rowe Associates Inc | 108,000 | $177.0K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 189,935 | $311.5K | 0.13% | 00.0% | Unchanged |
| Raymond James & Associates | 212,703 | $348.8K | 0.00% | −32,100−13.1% | Reduced |
| Geode Capital Management, LLC | 273,706 | $448.0K | 0.00% | −2,930−1.1% | Reduced |
| Abner Herrman & Brock LLC | 280,000 | $459.0K | 0.07% | 00.0% | Unchanged |
| BlackRock Inc. | 471,772 | $773.7K | 0.00% | +3,452+0.7% | Added |
| Vanguard Group Inc | 1,428,533 | $2.34M | 0.00% | +6310.0% | Added |
| Cypress Capital Management LLC (WY) | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −11,448−100.0% | Sold out |
| Aptus Capital Advisors, LLC | 0 | $0 | 0.00% | −10,360−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Tru Independence Asset Management 2, LLC | – | – | – | – | Not filed |
| Liberty Wealth Management LLC | – | – | – | – | Not filed |